カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒアルロニダーゼパワーインジェクション市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Hyaluronidase Power Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19404）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19404
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒアルロニダーゼパワーインジェクション市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒアルロニダーゼパワーインジェクション市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒアルロニダーゼパワーインジェクションの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒアルロニダーゼパワーインジェクション市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・合成動物由来ヒアルロニダーゼ、バイオエンジニアリングヒアルロニダーゼ

用途別セグメントは次のように区分されます。
・化学療法、皮膚科、眼科、形成外科、その他

世界のヒアルロニダーゼパワーインジェクション市場の主要な市場プレーヤーは以下のとおりです。
・PrimaPharm、Sun Pharmaceuticals Industries、Bausch Health、Halozyme Therapeutics、CooperSurgical Fertility、Amphastar Pharmaceuticals、Shreya Life Science、Stemcell Technologies、Anika Therapeutics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒアルロニダーゼパワーインジェクション製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒアルロニダーゼパワーインジェクションメーカーの企業概要、2019年～2022年までのヒアルロニダーゼパワーインジェクションの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒアルロニダーゼパワーインジェクションメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒアルロニダーゼパワーインジェクションの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒアルロニダーゼパワーインジェクションの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒアルロニダーゼパワーインジェクション市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒアルロニダーゼパワーインジェクションの産業チェーンを掲載しています。
・第13、14、15章では、ヒアルロニダーゼパワーインジェクションの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヒアルロニダーゼパワーインジェクションの概要
- 種類別分析（2017年vs2021年vs2028年）：合成動物由来ヒアルロニダーゼ、バイオエンジニアリングヒアルロニダーゼ
- 用途別分析（2017年vs2021年vs2028年）：化学療法、皮膚科、眼科、形成外科、その他
- 世界のヒアルロニダーゼパワーインジェクション市場規模・予測
- 世界のヒアルロニダーゼパワーインジェクション生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- PrimaPharm、Sun Pharmaceuticals Industries、Bausch Health、Halozyme Therapeutics、CooperSurgical Fertility、Amphastar Pharmaceuticals、Shreya Life Science、Stemcell Technologies、Anika Therapeutics
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：合成動物由来ヒアルロニダーゼ、バイオエンジニアリングヒアルロニダーゼ
・用途別分析2017年-2028年：化学療法、皮膚科、眼科、形成外科、その他
・ヒアルロニダーゼパワーインジェクションの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒアルロニダーゼパワーインジェクションのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒアルロニダーゼパワーインジェクションのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒアルロニダーゼパワーインジェクションの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒアルロニダーゼパワーインジェクションの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Hyaluronidase Power Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hyaluronidase Power Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chemotherapy accounting for % of the Hyaluronidase Power Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Synthetic Animal-Derived Hyaluronidase segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hyaluronidase Power Injection include PrimaPharm, Sun Pharmaceuticals Industries, Bausch Health, Halozyme Therapeutics, and CooperSurgical Fertility, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hyaluronidase Power Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Synthetic Animal-Derived Hyaluronidase
Bio-Engineered Hyaluronidase
Market segment by Application can be divided into
Chemotherapy
Dermatology
Ophthalmology
Plastic Surgery
Others
The key market players for global Hyaluronidase Power Injection market are listed below:
PrimaPharm
Sun Pharmaceuticals Industries
Bausch Health
Halozyme Therapeutics
CooperSurgical Fertility
Amphastar Pharmaceuticals
Shreya Life Science
Stemcell Technologies
Anika Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyaluronidase Power Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyaluronidase Power Injection, with price, sales, revenue and global market share of Hyaluronidase Power Injection from 2019 to 2022.
Chapter 3, the Hyaluronidase Power Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyaluronidase Power Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hyaluronidase Power Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hyaluronidase Power Injection.
Chapter 13, 14, and 15, to describe Hyaluronidase Power Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Hyaluronidase Power Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hyaluronidase Power Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Synthetic Animal-Derived Hyaluronidase
1.2.3 Bio-Engineered Hyaluronidase
1.3 Market Analysis by Application
1.3.1 Overview: Global Hyaluronidase Power Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chemotherapy
1.3.3 Dermatology
1.3.4 Ophthalmology
1.3.5 Plastic Surgery
1.3.6 Others
1.4 Global Hyaluronidase Power Injection Market Size & Forecast
1.4.1 Global Hyaluronidase Power Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hyaluronidase Power Injection Sales in Volume (2017-2028)
1.4.3 Global Hyaluronidase Power Injection Price (2017-2028)
1.5 Global Hyaluronidase Power Injection Production Capacity Analysis
1.5.1 Global Hyaluronidase Power Injection Total Production Capacity (2017-2028)
1.5.2 Global Hyaluronidase Power Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hyaluronidase Power Injection Market Drivers
1.6.2 Hyaluronidase Power Injection Market Restraints
1.6.3 Hyaluronidase Power Injection Trends Analysis
2 Manufacturers Profiles
2.1 PrimaPharm
2.1.1 PrimaPharm Details
2.1.2 PrimaPharm Major Business
2.1.3 PrimaPharm Hyaluronidase Power Injection Product and Services
2.1.4 PrimaPharm Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sun Pharmaceuticals Industries
2.2.1 Sun Pharmaceuticals Industries Details
2.2.2 Sun Pharmaceuticals Industries Major Business
2.2.3 Sun Pharmaceuticals Industries Hyaluronidase Power Injection Product and Services
2.2.4 Sun Pharmaceuticals Industries Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Hyaluronidase Power Injection Product and Services
2.3.4 Bausch Health Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Halozyme Therapeutics
2.4.1 Halozyme Therapeutics Details
2.4.2 Halozyme Therapeutics Major Business
2.4.3 Halozyme Therapeutics Hyaluronidase Power Injection Product and Services
2.4.4 Halozyme Therapeutics Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CooperSurgical Fertility
2.5.1 CooperSurgical Fertility Details
2.5.2 CooperSurgical Fertility Major Business
2.5.3 CooperSurgical Fertility Hyaluronidase Power Injection Product and Services
2.5.4 CooperSurgical Fertility Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Amphastar Pharmaceuticals
2.6.1 Amphastar Pharmaceuticals Details
2.6.2 Amphastar Pharmaceuticals Major Business
2.6.3 Amphastar Pharmaceuticals Hyaluronidase Power Injection Product and Services
2.6.4 Amphastar Pharmaceuticals Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shreya Life Science
2.7.1 Shreya Life Science Details
2.7.2 Shreya Life Science Major Business
2.7.3 Shreya Life Science Hyaluronidase Power Injection Product and Services
2.7.4 Shreya Life Science Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Stemcell Technologies
2.8.1 Stemcell Technologies Details
2.8.2 Stemcell Technologies Major Business
2.8.3 Stemcell Technologies Hyaluronidase Power Injection Product and Services
2.8.4 Stemcell Technologies Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Anika Therapeutics
2.9.1 Anika Therapeutics Details
2.9.2 Anika Therapeutics Major Business
2.9.3 Anika Therapeutics Hyaluronidase Power Injection Product and Services
2.9.4 Anika Therapeutics Hyaluronidase Power Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hyaluronidase Power Injection Breakdown Data by Manufacturer
3.1 Global Hyaluronidase Power Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hyaluronidase Power Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hyaluronidase Power Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Hyaluronidase Power Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Hyaluronidase Power Injection Manufacturer Market Share in 2021
3.5 Global Hyaluronidase Power Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hyaluronidase Power Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hyaluronidase Power Injection Market Size by Region
4.1.1 Global Hyaluronidase Power Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Hyaluronidase Power Injection Revenue by Region (2017-2028)
4.2 North America Hyaluronidase Power Injection Revenue (2017-2028)
4.3 Europe Hyaluronidase Power Injection Revenue (2017-2028)
4.4 Asia-Pacific Hyaluronidase Power Injection Revenue (2017-2028)
4.5 South America Hyaluronidase Power Injection Revenue (2017-2028)
4.6 Middle East and Africa Hyaluronidase Power Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hyaluronidase Power Injection Sales in Volume by Type (2017-2028)
5.2 Global Hyaluronidase Power Injection Revenue by Type (2017-2028)
5.3 Global Hyaluronidase Power Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hyaluronidase Power Injection Sales in Volume by Application (2017-2028)
6.2 Global Hyaluronidase Power Injection Revenue by Application (2017-2028)
6.3 Global Hyaluronidase Power Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hyaluronidase Power Injection Sales by Type (2017-2028)
7.2 North America Hyaluronidase Power Injection Sales by Application (2017-2028)
7.3 North America Hyaluronidase Power Injection Market Size by Country
7.3.1 North America Hyaluronidase Power Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Hyaluronidase Power Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hyaluronidase Power Injection Sales by Type (2017-2028)
8.2 Europe Hyaluronidase Power Injection Sales by Application (2017-2028)
8.3 Europe Hyaluronidase Power Injection Market Size by Country
8.3.1 Europe Hyaluronidase Power Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Hyaluronidase Power Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hyaluronidase Power Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Hyaluronidase Power Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Hyaluronidase Power Injection Market Size by Region
9.3.1 Asia-Pacific Hyaluronidase Power Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hyaluronidase Power Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hyaluronidase Power Injection Sales by Type (2017-2028)
10.2 South America Hyaluronidase Power Injection Sales by Application (2017-2028)
10.3 South America Hyaluronidase Power Injection Market Size by Country
10.3.1 South America Hyaluronidase Power Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Hyaluronidase Power Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hyaluronidase Power Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Hyaluronidase Power Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Hyaluronidase Power Injection Market Size by Country
11.3.1 Middle East & Africa Hyaluronidase Power Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hyaluronidase Power Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hyaluronidase Power Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hyaluronidase Power Injection
12.3 Hyaluronidase Power Injection Production Process
12.4 Hyaluronidase Power Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hyaluronidase Power Injection Typical Distributors
13.3 Hyaluronidase Power Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Hyaluronidase Power Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hyaluronidase Power Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. PrimaPharm Basic Information, Manufacturing Base and Competitors
Table 4. PrimaPharm Major Business
Table 5. PrimaPharm Hyaluronidase Power Injection Product and Services
Table 6. PrimaPharm Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sun Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table 8. Sun Pharmaceuticals Industries Major Business
Table 9. Sun Pharmaceuticals Industries Hyaluronidase Power Injection Product and Services
Table 10. Sun Pharmaceuticals Industries Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 12. Bausch Health Major Business
Table 13. Bausch Health Hyaluronidase Power Injection Product and Services
Table 14. Bausch Health Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Halozyme Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. Halozyme Therapeutics Major Business
Table 17. Halozyme Therapeutics Hyaluronidase Power Injection Product and Services
Table 18. Halozyme Therapeutics Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CooperSurgical Fertility Basic Information, Manufacturing Base and Competitors
Table 20. CooperSurgical Fertility Major Business
Table 21. CooperSurgical Fertility Hyaluronidase Power Injection Product and Services
Table 22. CooperSurgical Fertility Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Amphastar Pharmaceuticals Major Business
Table 25. Amphastar Pharmaceuticals Hyaluronidase Power Injection Product and Services
Table 26. Amphastar Pharmaceuticals Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shreya Life Science Basic Information, Manufacturing Base and Competitors
Table 28. Shreya Life Science Major Business
Table 29. Shreya Life Science Hyaluronidase Power Injection Product and Services
Table 30. Shreya Life Science Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 32. Stemcell Technologies Major Business
Table 33. Stemcell Technologies Hyaluronidase Power Injection Product and Services
Table 34. Stemcell Technologies Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Anika Therapeutics Major Business
Table 37. Anika Therapeutics Hyaluronidase Power Injection Product and Services
Table 38. Anika Therapeutics Hyaluronidase Power Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Hyaluronidase Power Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Hyaluronidase Power Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Hyaluronidase Power Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Hyaluronidase Power Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Hyaluronidase Power Injection Production Site of Key Manufacturer
Table 44. Hyaluronidase Power Injection New Entrant and Capacity Expansion Plans
Table 45. Hyaluronidase Power Injection Mergers & Acquisitions in the Past Five Years
Table 46. Global Hyaluronidase Power Injection Sales by Region (2017-2022) & (K Units)
Table 47. Global Hyaluronidase Power Injection Sales by Region (2023-2028) & (K Units)
Table 48. Global Hyaluronidase Power Injection Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Hyaluronidase Power Injection Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Hyaluronidase Power Injection Sales by Type (2017-2022) & (K Units)
Table 51. Global Hyaluronidase Power Injection Sales by Type (2023-2028) & (K Units)
Table 52. Global Hyaluronidase Power Injection Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Hyaluronidase Power Injection Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Hyaluronidase Power Injection Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Hyaluronidase Power Injection Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Hyaluronidase Power Injection Sales by Application (2017-2022) & (K Units)
Table 57. Global Hyaluronidase Power Injection Sales by Application (2023-2028) & (K Units)
Table 58. Global Hyaluronidase Power Injection Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Hyaluronidase Power Injection Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Hyaluronidase Power Injection Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Hyaluronidase Power Injection Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Hyaluronidase Power Injection Sales by Country (2017-2022) & (K Units)
Table 63. North America Hyaluronidase Power Injection Sales by Country (2023-2028) & (K Units)
Table 64. North America Hyaluronidase Power Injection Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Hyaluronidase Power Injection Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Hyaluronidase Power Injection Sales by Type (2017-2022) & (K Units)
Table 67. North America Hyaluronidase Power Injection Sales by Type (2023-2028) & (K Units)
Table 68. North America Hyaluronidase Power Injection Sales by Application (2017-2022) & (K Units)
Table 69. North America Hyaluronidase Power Injection Sales by Application (2023-2028) & (K Units)
Table 70. Europe Hyaluronidase Power Injection Sales by Country (2017-2022) & (K Units)
Table 71. Europe Hyaluronidase Power Injection Sales by Country (2023-2028) & (K Units)
Table 72. Europe Hyaluronidase Power Injection Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Hyaluronidase Power Injection Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Hyaluronidase Power Injection Sales by Type (2017-2022) & (K Units)
Table 75. Europe Hyaluronidase Power Injection Sales by Type (2023-2028) & (K Units)
Table 76. Europe Hyaluronidase Power Injection Sales by Application (2017-2022) & (K Units)
Table 77. Europe Hyaluronidase Power Injection Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Hyaluronidase Power Injection Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Hyaluronidase Power Injection Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Hyaluronidase Power Injection Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Hyaluronidase Power Injection Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Hyaluronidase Power Injection Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Hyaluronidase Power Injection Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Hyaluronidase Power Injection Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Hyaluronidase Power Injection Sales by Application (2023-2028) & (K Units)
Table 86. South America Hyaluronidase Power Injection Sales by Country (2017-2022) & (K Units)
Table 87. South America Hyaluronidase Power Injection Sales by Country (2023-2028) & (K Units)
Table 88. South America Hyaluronidase Power Injection Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Hyaluronidase Power Injection Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Hyaluronidase Power Injection Sales by Type (2017-2022) & (K Units)
Table 91. South America Hyaluronidase Power Injection Sales by Type (2023-2028) & (K Units)
Table 92. South America Hyaluronidase Power Injection Sales by Application (2017-2022) & (K Units)
Table 93. South America Hyaluronidase Power Injection Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Hyaluronidase Power Injection Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Hyaluronidase Power Injection Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Hyaluronidase Power Injection Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Hyaluronidase Power Injection Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Hyaluronidase Power Injection Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Hyaluronidase Power Injection Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Hyaluronidase Power Injection Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Hyaluronidase Power Injection Sales by Application (2023-2028) & (K Units)
Table 102. Hyaluronidase Power Injection Raw Material
Table 103. Key Manufacturers of Hyaluronidase Power Injection Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Hyaluronidase Power Injection Typical Distributors
Table 107. Hyaluronidase Power Injection Typical Customers
List of Figures
Figure 1. Hyaluronidase Power Injection Picture
Figure 2. Global Hyaluronidase Power Injection Revenue Market Share by Type in 2021
Figure 3. Synthetic Animal-Derived Hyaluronidase
Figure 4. Bio-Engineered Hyaluronidase
Figure 5. Global Hyaluronidase Power Injection Revenue Market Share by Application in 2021
Figure 6. Chemotherapy
Figure 7. Dermatology
Figure 8. Ophthalmology
Figure 9. Plastic Surgery
Figure 10. Others
Figure 11. Global Hyaluronidase Power Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Hyaluronidase Power Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Hyaluronidase Power Injection Sales (2017-2028) & (K Units)
Figure 14. Global Hyaluronidase Power Injection Price (2017-2028) & (US$/Unit)
Figure 15. Global Hyaluronidase Power Injection Production Capacity (2017-2028) & (K Units)
Figure 16. Global Hyaluronidase Power Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Hyaluronidase Power Injection Market Drivers
Figure 18. Hyaluronidase Power Injection Market Restraints
Figure 19. Hyaluronidase Power Injection Market Trends
Figure 20. Global Hyaluronidase Power Injection Sales Market Share by Manufacturer in 2021
Figure 21. Global Hyaluronidase Power Injection Revenue Market Share by Manufacturer in 2021
Figure 22. Hyaluronidase Power Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Hyaluronidase Power Injection Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Hyaluronidase Power Injection Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Hyaluronidase Power Injection Sales Market Share by Region (2017-2028)
Figure 26. Global Hyaluronidase Power Injection Revenue Market Share by Region (2017-2028)
Figure 27. North America Hyaluronidase Power Injection Revenue (2017-2028) & (USD Million)
Figure 28. Europe Hyaluronidase Power Injection Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Hyaluronidase Power Injection Revenue (2017-2028) & (USD Million)
Figure 30. South America Hyaluronidase Power Injection Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Hyaluronidase Power Injection Revenue (2017-2028) & (USD Million)
Figure 32. Global Hyaluronidase Power Injection Sales Market Share by Type (2017-2028)
Figure 33. Global Hyaluronidase Power Injection Revenue Market Share by Type (2017-2028)
Figure 34. Global Hyaluronidase Power Injection Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Hyaluronidase Power Injection Sales Market Share by Application (2017-2028)
Figure 36. Global Hyaluronidase Power Injection Revenue Market Share by Application (2017-2028)
Figure 37. Global Hyaluronidase Power Injection Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Hyaluronidase Power Injection Sales Market Share by Type (2017-2028)
Figure 39. North America Hyaluronidase Power Injection Sales Market Share by Application (2017-2028)
Figure 40. North America Hyaluronidase Power Injection Sales Market Share by Country (2017-2028)
Figure 41. North America Hyaluronidase Power Injection Revenue Market Share by Country (2017-2028)
Figure 42. United States Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Hyaluronidase Power Injection Sales Market Share by Type (2017-2028)
Figure 46. Europe Hyaluronidase Power Injection Sales Market Share by Application (2017-2028)
Figure 47. Europe Hyaluronidase Power Injection Sales Market Share by Country (2017-2028)
Figure 48. Europe Hyaluronidase Power Injection Revenue Market Share by Country (2017-2028)
Figure 49. Germany Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Hyaluronidase Power Injection Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Hyaluronidase Power Injection Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Hyaluronidase Power Injection Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Hyaluronidase Power Injection Revenue Market Share by Region (2017-2028)
Figure 58. China Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Hyaluronidase Power Injection Sales Market Share by Type (2017-2028)
Figure 65. South America Hyaluronidase Power Injection Sales Market Share by Application (2017-2028)
Figure 66. South America Hyaluronidase Power Injection Sales Market Share by Country (2017-2028)
Figure 67. South America Hyaluronidase Power Injection Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Hyaluronidase Power Injection Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Hyaluronidase Power Injection Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Hyaluronidase Power Injection Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Hyaluronidase Power Injection Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Hyaluronidase Power Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Hyaluronidase Power Injection in 2021
Figure 79. Manufacturing Process Analysis of Hyaluronidase Power Injection
Figure 80. Hyaluronidase Power Injection Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のリラグルチド注射市場2022年：市場規模予測（～2028年）
  • 世界のエダラボン注射市場2022年：市場規模予測（～2028年）
  • 世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）
  • 世界のクリスビタ注射市場2022年：市場規模予測（～2028年）
  • 世界のヴェノファー（鉄ショ糖注射液）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19404 )"世界のヒアルロニダーゼパワーインジェクション市場2022年：市場規模予測（～2028年）" (英文：Global Hyaluronidase Power Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。